News for ProQR Therapeutics N.V. (PRQR)

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV ( PRQR) (ProQR), a company dedicated to changing lives through

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. ( PRQR) (ProQR), a company dedicated to changing lives throug

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. ( PRQR) (ProQR), a company dedicated to changing lives throu

**media[594192]**

Axiomerâ„¢ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting N

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

**media[489367]**

ProQR secures $9.1M for Rett syndrome trial

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. ( PRQR) (ProQR), a company dedicated to changing lives throug

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. ( PRQR) (ProQR), a company dedicated to changing lives throu

U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday. Shares of Neurogene Inc. NGNE fell sharply in today's ...

AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual Investor and...

**media[447379]**

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

Connecticut-based Nixxy, Inc. (NIXX) is up over 216 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of Taiwan Semiconductor Manufacturing Company Limited TSM rose sharply in today's pre-market trading following better-than-expected quarterly results. T...

WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and...

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.